Is an alanine aminotransferase (ALT) of 133 U/L and aspartate aminotransferase (AST) of 78 U/L concerning?

Yes, these liver enzyme levels are elevated and warrant evaluation

An ALT of 133 U/L and AST of 78 U/L represent mild hepatocellular injury that requires investigation to identify the underlying cause and assess for potential progression to significant liver disease.

Understanding Your Results

Your liver enzymes show a hepatocellular pattern of injury (ALT elevated more than AST), classified as mild elevation since both values are less than 5 times the upper limit of normal 1. However, "mild" does not mean insignificant—these levels indicate active liver cell damage that needs explanation.

Key Context About Normal Values

The traditional upper limits of normal (often 40 U/L) used by many laboratories are actually too high and miss significant liver disease 2, 3:

• Updated normal ALT ranges: 29-33 U/L for men, 19-25 U/L for women 1
• Your ALT of 133 U/L is approximately 4-7 times these updated normal values
• Your AST of 78 U/L is approximately 2-3 times normal

The AST:ALT ratio of approximately 0.6 (<1) suggests **metabolic liver disease** rather than alcohol-related injury, which typically shows ratios >2 1.

Most Likely Causes to Investigate

Based on current guidelines, the most common causes of this pattern are 1:

Primary Considerations:

• Nonalcoholic fatty liver disease (NAFLD): Most common cause (20-30% general population prevalence, up to 70% with obesity, 90% with diabetes)
• Alcohol-induced liver disease: If consuming >2 drinks/day for men or >1 drink/day for women
• Viral hepatitis: Hepatitis B or C
• Medication/supplement-induced injury: Including over-the-counter drugs, herbal supplements

Secondary Considerations:

• Hemochromatosis (iron overload)
• Autoimmune hepatitis
• Alpha-1 antitrypsin deficiency
• Wilson disease (if age <40)

Immediate Next Steps

Do not simply repeat the tests and wait—this delays diagnosis of potentially progressive disease 4. Instead:

1. Clinical Assessment

Evaluate for:

• Metabolic risk factors: Body mass index, waist circumference, diabetes, hypertension, dyslipidemia
• Alcohol consumption: Quantity and frequency (be honest with your physician)
• Medication/supplement review: Everything including vitamins, herbs, over-the-counter products
• Symptoms: Fatigue, right upper quadrant pain, jaundice, itching
• Family history: Liver disease, cirrhosis, liver cancer

2. Initial Laboratory Workup

Order simultaneously (not sequentially) 5:

• Viral hepatitis panel: Hepatitis B surface antigen, hepatitis C antibody
• Metabolic panel: Fasting glucose, lipid panel, hemoglobin A1c
• Iron studies: Ferritin, transferrin saturation (for hemochromatosis)
• Additional liver tests: Alkaline phosphatase, bilirubin, albumin, prothrombin time/INR

3. Imaging

Abdominal ultrasound is the appropriate first-line imaging 1:

• Detects fatty liver (steatosis >33% with 84.8% sensitivity, 93.6% specificity)
• Identifies structural abnormalities
• Non-invasive and cost-effective
• Should be obtained now, not after repeat blood tests

Critical Pitfalls to Avoid

1. Don't assume normal repeat tests mean no disease: NAFLD and hepatitis C can have fluctuating or even normal ALT levels while fibrosis progresses 4

2. Don't wait for symptoms: Most chronic liver diseases are asymptomatic until advanced stages

3. Don't ignore based on "mild" classification: The extent of enzyme elevation does not reliably predict disease severity or prognosis 4. Patients with these levels can have significant fibrosis.

4. Don't overlook medications/supplements: These are frequently missed causes of liver injury

When to Escalate Care

Seek immediate evaluation if you develop 6:

• Jaundice (yellowing of skin/eyes)
• Severe fatigue, nausea, vomiting
• Right upper quadrant pain
• Any elevation in bilirubin
• Confusion or altered mental status

Consider gastroenterology/hepatology referral if:

• Initial workup identifies chronic liver disease
• Enzymes remain elevated after 6 months
• Evidence of advanced fibrosis on imaging or non-invasive testing
• Bilirubin becomes elevated (suggests more severe injury)

Prognosis Perspective

While these levels indicate liver injury requiring investigation, early detection allows intervention before irreversible damage occurs. NAFLD, the most common cause, can progress from simple steatosis to inflammation (NASH) to fibrosis to cirrhosis and hepatocellular carcinoma 1. However, with appropriate lifestyle modifications (weight loss, exercise, metabolic control) and treatment of underlying causes, progression can often be prevented or reversed.

The key is acting now rather than waiting—your liver enzymes are telling you something is wrong, and identifying the cause early maximizes your chances of preventing long-term complications including cirrhosis, liver failure, and liver cancer.